Chris LoBianco

Stock Analyst at TD Cowen

(2.03)

# 3,317

Out of 5,125 analysts

7

Total ratings

100%

Success rate

35.8%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - General

Stocks Rated by Chris LoBianco

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	JNJ Johnson & Johnson	Reiterated: Buy	$300	$259.51	+15.60%	1	Oct 20, 2026
	NVAX Novavax	Rated: Hold	$9	$10.82	-16.82%	5	Aug 4, 2026
	RPRX Royalty Pharma	Initiated Coverage: Buy	$42	$60.27	n/a	1	Jun 26, 2025

Johnson & Johnson

Oct 20, 2026

Reiterated: Buy

Price Target: $300

Current: $259.51

Upside: +15.60%

Novavax

Aug 4, 2026

Rated: Hold

Price Target: $9

Current: $10.82

Upside: -16.82%

Royalty Pharma

Jun 26, 2025

Initiated Coverage: Buy

Price Target: $42

Current: $60.27

Upside: n/a